Sources | Names Used |
---|---|
CTRPv2 | Compound 1541A |
PharmacoGx | Compound 1541A |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ARHGEF9 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
mRNA | CASP8AP2 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
mRNA | C1QL2 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
mRNA | CYP2R1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.01 |
mRNA | BSDC1 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
mRNA | ABRACL | CTRPv2 | pan-cancer | AAC | 0.11 | 0.01 |
mRNA | ZRSR2 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
mRNA | ZNF71 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.01 |
mRNA | ZNF574 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.01 |
mRNA | GABRA2 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |